Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

Shanghai ZJ Bio-Tech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,460	2,783	2,769	3,148	2,936	1,205
Cash & Short-Term Investments	2,815	2,783	2,769	3,148	2,936	1,205
Cash Growth	2.56%	0.50%	-12.02%	7.21%	143.70%	389.55%
Accounts Receivable	38.18	55.27	102.1	227.63	218.39	230.37
Other Receivables	4.91	22.78	25.05	9.45	75.76	1.4
Receivables	43.08	78.05	127.15	237.08	294.15	231.77
Inventory	52.6	57.37	253.6	504.03	299.47	131.73
Other Current Assets	27.57	16.8	15.79	21.01	23.3	14.71
Total Current Assets	2,938	2,936	3,166	3,910	3,553	1,583
Property, Plant & Equipment	645.01	680.95	743.91	661.63	562.36	125.04
Long-Term Investments	65.51	95.46	101.05	113.46	74.97	154.12
Goodwill	5.4	5.4	5.4	5.4	5.4	5.4
Other Intangible Assets	6.7	7.8	6.06	6.84	6.57	3.69
Long-Term Deferred Tax Assets	57.4	60.8	37.16	9.46	7.44	7.39
Long-Term Deferred Charges	3.22	3.82	2.86	3.66	-	-
Other Long-Term Assets	-	0.11	11.71	33.55	45.1	1.01
Total Assets	3,721	3,790	4,074	4,744	4,255	1,880
Accounts Payable	66.23	62.46	120.58	317.67	236.95	159.57
Accrued Expenses	36.74	59.96	74.03	99.78	75.92	112.58
Current Portion of Leases	1.67	1.73	2.81	2.94	-	-
Current Income Taxes Payable	3.07	0.09	0.01	26.82	32.28	53.34
Current Unearned Revenue	13.17	15.28	24.02	59.32	55.29	50.54
Other Current Liabilities	6.5	6.46	15.12	17.33	8.56	9.36
Total Current Liabilities	127.39	145.99	236.56	523.86	409	385.39
Long-Term Debt	196.02	-	-	-	-	-
Long-Term Leases	2.82	3.19	4.64	5.69	-	-
Long-Term Unearned Revenue	0.94	3.88	7.59	11.71	13.74	17.54
Long-Term Deferred Tax Liabilities	-	-	0.45	2.17	4.54	14.04
Total Liabilities	327.17	153.06	249.25	543.44	427.27	416.97
Common Stock	192.16	192.16	194.7	194.7	194.7	146.03
Additional Paid-In Capital	2,051	2,051	2,150	2,150	2,150	256.54
Retained Earnings	1,415	1,438	1,587	1,953	1,458	981.08
Treasury Stock	-255.31	-35.33	-102.03	-102.03	-	-
Comprehensive Income & Other	-8.84	-8.88	-4.51	4.73	24.35	78.95
Total Common Equity	3,394	3,637	3,825	4,200	3,827	1,463
Shareholders' Equity	3,394	3,637	3,825	4,200	3,827	1,463
Total Liabilities & Equity	3,721	3,790	4,074	4,744	4,255	1,880
Total Debt	200.51	4.93	7.45	8.63	-	-
Net Cash (Debt)	2,614	2,778	2,762	3,139	2,936	1,205
Net Cash Growth	-4.57%	0.60%	-12.01%	6.92%	143.70%	389.55%
Net Cash Per Share	13.86	14.60	14.33	16.23	15.40	8.25
Filing Date Shares Outstanding	177.52	189.84	192.16	192.16	194.7	194.7
Total Common Shares Outstanding	177.52	189.84	192.16	192.16	194.7	146.03
Working Capital	2,810	2,790	2,929	3,386	3,144	1,198
Book Value Per Share	19.12	19.16	19.91	21.86	19.66	10.02
Tangible Book Value	3,382	3,624	3,813	4,188	3,815	1,454
Tangible Book Value Per Share	19.05	19.09	19.85	21.80	19.60	9.95
Buildings	-	770.99	757.66	639.77	547.36	108.22
Machinery	-	156.51	208.32	194.57	145.72	128.58
Construction In Progress	-	0.34	2.12	1.18	0.98	1.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.